SPRs supported by the School of Medicine, London Deanery.
Organising committee: Mr. Fausto Palazzo, Dr. Waljit Dhillo,
Professor. Karim Meeran, Professor Stephen Bloom
8.30 Registration & Coffee
8.45 Mr. Fausto Palazzo, Prof Karim Meeran and Dr. Waljit Dhillo: Welcome and Introduction
9.00 - 11.00: Phaeochromocytoma session
9.00 Recent advances in the localisation of phaeochromocytomas and paragangliomas
Dr Bomanji (University College Hospital, London).
What imaging modalities are available?
9.30 Current options in the pre-operative preparation of phaeochromocytomas
Prof John Wass (Oxford)
Recent advances in their management.
10.00 Safe surgery: Phaeochromocytoma anaesthesia Dr Parind Patel (Hammersmith Hospital)
How to ensure a good outcome
10.20 Clinical cases & delegate participation
OC1: Limitations of functional imaging in phaeochromocytoma (Anjali Amin)
OC2: Rare Phaeo type: also to discuss order of beta and alpha blockade (Rahila Bhatti, Masud Haq and Dennis Barnes)
OC3: Difficulties in the management of hypercortisolism Dr FW Ahmed, Dr D Sennik, Dr J Wright and Professor D Russell-Jones
11.00 Coffee Break
11.30 - 12.50: Conn's session.
Chair: Karim Meeran
11.30 Developments in the diagnosis and imaging of Hyperaldosteronism
Prof Morris Brown (University of Cambridge)
What investigations should we do?
11.55: Update on Conn’s case from last year
(Karim Meeran)
12.00 Interventional radiology in Hyperaldoseronism
: Dr James Jackson (Hammersmith Hospital)
Technique, tips and pitfalls
12.30 Clinical cases & delegate participation
12.30 Case presentation:
OC4: A difficult case of Conn’s : Vicky Salem
12.50 The Society for Endocrinology Poster session and Luncheon + MEN cases
The Society for Endocrinology International Seminar
Chair Fausto Palazzo
2.00 State of the art minimally invasive adrenal surgery
Prof Martin Walz (Essen, Germany)
3.00 Coffee break
3.30 - 5.00: Graves debate
Chair: Dr. Waljit Dhillo
3.30 Surgery should be adopted more frequently in Graves’ thyrotoxicosis Mr David Scott Coombes (Cardiff)
Prevention, medical management and the indications for surgery
4.00 Radioiodine should be the definitive treatment of choice in Graves’ disease
Prof Karim Meeran (Imperial College)
4.30 clinical Cases
OC5: Thionamide induced agranulocytosis in a patient with Graves’ thyrotoxicosis.
Richard Carroll (Ealing)
OC6: Should thyroid surgery be the treatment of choice for thyrotoxic parents with young children? A Falinska and K Ahmed (West Middlesex)